EGFR and lung adenocarcinoma: In 2013 International association for lung cancer research (IASLC) amended and supplemented the Martini-Melamed criteria, by multidisciplinary classification of lung adenocarcinoma, epidermal growth factor receptor (EGFR), K-ras added for differential diagnosis.